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Summary points
• Determining sexual contact as a mode of pathogen transmission and quantifying the
risk of sexual transmission pose epidemiologic challenges.
• Prior experiences with nontraditional sexually transmitted infections present valuable
epidemiologic lessons, including comparisons of disease rates by sex, molecular analyses
among sexually linked clusters, and methods to control for other potential modes of
transmission.
• Applying lessons learned from prior infections might be critical for rapid and effective
detection, prevention, and control of other reemerging and newly recognized sexually
transmitted infections.
The spectrum of pathogens that have a sexually transmitted component is broad. Globally,
there are more than 30 recognized sexually transmitted infections (STIs), including those
transmitted primarily by sexual contact and those that are sexually transmissible but whose
primary mode of transmission is by food, vector, or droplet [1]. This latter group of nontradi-
tional STIs poses unique methodologic and epidemiologic challenges for public health prac-
titioners and researchers, who need to anticipate, identify, and contain the next new STI
outbreak. In this paper, we explore these challenges using examples of nontraditional STIs,
including 2 (shigellosis and Neisseria meningitidis) that have recently reemerged as sexually
transmissible and 2 (Zika and Ebola) that are newly recognized as being sexually transmissible
(Table 1).
Shigella: Raised male-to-female ratios in routine surveillance data
Shigellosis is a diarrheal illness caused by several species of the bacterium Shigella. Shigella is
transmitted by direct or indirect contact with human feces, often via contaminated food,
water, or fomites [13]. Prior to the 1970s, Shigella incidence was highest among children <5
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years of age, their caretakers, and travelers to less developed countries. Recognition of Shigella
as a potential STI began in the 1970s with outbreaks among men who have sex with men
(MSM) in the US [8, 9, 14, 15]. Sexual transmission of Shigella likely occurs during oral-anal
sex (e.g., anilingus or rimming) or digital-anal sex (e.g., fisting) [16, 17]. During the 1970s and
1980s, Shigella flexneri rates increased in the US among adult males, even as overall rates and
rates among children declined [18]. Routine case reports for Shigella do not include informa-
tion about sexual practices, but the widening disparity between adult male and female case
rates strongly suggested male-male sexual transmission. Increases in Shigella among men in
the US and England between 2004 and 2015—despite declining or steady rates among women
and children—support the reemergence of Shigella as an STI among MSM [19, 20]. Shigella
Table 1. Modes of emergence and key characteristics of selected sexually transmitted infections.
HIV N. meningitidis Mycoplasma
genitalium
Shigella spp.,
Entamoeba
histolytica, and
Giardia lamblia
Zika virus Ebola virus
Mode of
emergence
New pathogen in
humans, newly
recognized disease
Newly discovered
pathogen, known genital
disease
Newly discovered
pathogen, known
genital disease
Recognized
pathogen,
extragenital site
Recognized
pathogen, newly
recognized mode of
transmission
Recognized
pathogen, newly
recognized
mode of
transmission
Mode of
discovery
New disease, AIDS,
United States, 1981 [2].
HIV transmission began
much earlier in sub-
Saharan Africa but was
unrecognized [3].
Isolation from men with
urethritis, US, 1942 [4]
Isolation from men
with nongonococcal
urethritis, United
Kingdom, 1981 [5]
Outbreaks in
MSM, proctitis,
US, 1960s and
1970s [6–9]
Sexual partner in US
of returning traveler
from Senegal, 2011
[10]
Tail end of
epidemic,
Liberia, 2015
[11]
Year
pathogen first
reported
1983 [11] 1942 [4] 1981 [5] Early 20th century 1947 [12] 1977 [13]
Reservoir Human Human Human Environmental Human Zoonotic
Primary portal
of entry/exit
Mucosal surfaces
(genitourinary and
anorectum);
percutaneous
Mucosal surfaces
(mouth and
genitourinary)
Mucosal surfaces
(genitourinary and
anorectum)
Mucosal surfaces
(mouth and
anorectum)
Percutaneous Mucosal
surfaces
Primary mode
of
transmission
Direct contact (sexual
intercourse), injection,
and vertical transmission
Direct contact (sexual
intercourse) and droplet
transmission
Direct contact
(sexual intercourse)
Ingestion Vector-borne
(mosquito)
Direct contact
(touching)
Disease HIV infection and AIDS Nonspecific urethritis
and invasive
meningococcal disease
Nonspecific urethritis Proctitis Zika virus infection Ebola virus
disease
Type of
disease
Systemic Genital and systemic Genital Extragenital Systemic Systemic
Genital
symptoms
No Yes, when the infection
is localized to the genital
tract; no genital
symptoms in the
systemic (invasive) form
of the disease
Yes, typical Extragenital Not usual;
hematospermia
reported
Not usual
Persistence in
genital
secretions
Lifelong Not known Not known; up to a
year
Not present in
genital secretions
Usually less than a
year
Usually less than
a year
Curable? No Yes Yes Yes No No
MSM, men who have sex with men.
https://doi.org/10.1371/journal.pmed.1002474.t001
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strains among MSM have demonstrated increasing multidrug resistance over the past 5 years
[21–28], and recent genomic analyses suggest international spread of an antimicrobial-resis-
tant S. flexneri serotype among MSM [23].
N. meningitidis: The role of dyad and cluster analyses
N. meningitidis, the bacterium that causes invasive meningococcal disease (IMD), spreads pri-
marily by droplet transmission and infection of respiratory mucosa. Approximately 5%–10%
of healthy adults are nasopharyngeal carriers. N. meningitidis has been isolated from men with
urethritis [4]. A 1972 study described the transmission of N. meningitidis from a male chim-
panzee’s nasopharynx to his own urethra via oral-genital autoinoculation [29]. The authors
concluded that N. meningitidis in the human urogenital tract might be the result of oral-genital
sexual contact. Dyad and cluster analyses showing related strains of meningococci among
partners epidemiologically linked by female-to-male oral sex strengthen the argument for sex-
ual transmission leading to meningococcal urethritis [30, 31]. Recent molecular analyses sug-
gest that N. meningitidis has genetically adapted to the urogenital tract [32]. Recent IMD
outbreaks among MSM in Europe, Canada, and the US have also raised questions about the
role that sexual networks play in N. meningitidis transmission [33–38]. Droplet transmission
within MSM sexual networks could explain consistently higher N. meningitidis nasopharyngeal
carriage rates relative to heterosexual men [39, 40]. It remains challenging, however, to deter-
mine whether the primary mode of transmission in IMD outbreaks among MSM is oral-geni-
tal contact, open-mouth kissing, or droplet transmission via “close contact,” including the
sharing of living and sleeping spaces.
Ebola virus: Viral persistence in semen and genetic epidemiology
The largest outbreak of Ebola virus disease started in December 2013 in West Africa and led to
>28,000 confirmed cases and 11,310 deaths [41]. Almost all infections resulted from exposure
to acutely symptomatic infected persons or recently deceased Ebola patients. Concern about
possible sexual transmission of Ebola grew as the outbreak continued [42]. Anecdotal reports
of new Ebola infections occurring among persons not in close proximity to a symptomatic or
recently deceased person were followed by a report of a Liberian woman with Ebola, whose
only possible source of infection was her husband, a convalescing Ebola survivor [43]. The
husband had a positive PCR test for Ebola RNA in his semen 199 days after symptom onset,
and the homology between genetic sequences of the Ebola RNA from the man and woman
suggested that the only possible source of her infection was through sexual transmission [43,
44]. Ebola virus persistence in the semen of male survivors was documented in previous spo-
radic outbreaks [45, 46]. However, in the most recent West African outbreak, more robust sys-
tematic assessments found male survivors with Ebola virus RNA detected by PCR up to 565
days after symptom onset [47–49]. There is little evidence supporting viral persistence in other
body fluids [42]. Female-to-male sexual transmission of Ebola is likely inefficient, but data are
limited. Although the risk of transmission from semen exposure is considered small, the sheer
number of male Ebola survivors raised concern about potential flare-ups and new clusters as
the West African outbreak waned [50, 51]. Little is known about the public health impact of
Ebola persistence among high-risk groups such as sex workers and MSM.
Zika virus: Infections in sexual partners of travelers returning from
endemic areas
A large outbreak of Zika virus in Latin America and the Caribbean in 2015–2016 drew interna-
tional attention because of its reported association with microcephaly. By 2017, 84 countries
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and territories had evidence of Zika transmission [52]. While the predominant mode of Zika
transmission is through the bite of an infected Aedes spp. mosquito, sexual transmission was
documented when a scientist returned to the US from Senegal in 2008 and transmitted Zika to
his female sex partner who had not travelled [10]. Case reports from 13 countries have since
described probable sexual transmission of Zika—via oral, anal, and vaginal sex—to partners of
travelers returning from endemic areas. Suspected male-to-female sexual transmission was
reported in 27 couples, while only 1 case of female-to-male and 1 case of male-to-male sexual
transmission have been documented [53]. Most sexual transmission events occurred in symp-
tomatic couples, but the timing of suspected transmission relative to symptom onset ranges
greatly.
Persistent detection of Zika in genital fluids by reverse transcriptase (RT)-PCR and culture
provides additional evidence for the biological plausibility of sexual transmission. In Puerto
Rico, Zika was detected in the semen of 56% of convalescing men, with a median of 34 days
between symptom onset and undetectable virus levels [54]. The maximum reported durations
of RNA detection in genital fluids are as follows: 188 days in semen by RT-PCR [55], 69 days
in semen by culture [56], 3 days in vaginal fluid in RT-PCR, and 11 days in cervical mucus by
RT-PCR [57]. Investigation of Zika sexual transmission is complicated by several factors,
including difficulty distinguishing vector and sexual transmission in endemic settings and dif-
ficulty obtaining viral cultures to confirm that viral persistence represents infectiousness. It is
unclear whether controlling sexual transmission of Zika will contribute substantially to overall
control of Zika epidemics; mathematical models estimate the population attributable risk of
sexual transmission to be from 3% to 23% [58, 59]. Sustained sexual transmission of Zika is
unlikely in a general population, but clusters may occur within high-risk sexual networks [60].
Lessons learned to inform future efforts
Lessons learned from the STIs discussed above can help the public health community identify
newly emerging STIs and estimate the potential for an epidemic by sexual transmission. Sexual
transmissibility of Zika and Ebola viruses was identified when infections were detected in per-
sons who could only have been infected through sexual intercourse. In the case of meningo-
coccal urethritis, detection of the pathogen in an unexpected anatomic niche and molecular
linkage between index patients and their sexual partners established sexual transmissibility.
Sexual transmission of Shigella was identified by attention to epidemiological changes in the
affected populations. M. genitalium, another predominantly sexually transmitted pathogen,
was discovered in 1981 by scientists searching for causes of nonspecific urethritis (Table 1)
[56]. This discussion harkens back to the global HIV/AIDS epidemic. HIV crossed a species
barrier and spread undetected as a new pathogen and STI among humans for years, before its
identification as AIDS in MSM with unexplained immune suppression in San Francisco in
1981 [2,3].
Now is the optimal time to establish methods to assess whether an infectious agent is sexu-
ally transmissible and prepare for a new STI with pandemic potential. New or reemerging
pathogens that are sexually transmissible will continue to arise. Since HIV was discovered,
new molecular tools, such as phylogenetics and the omics, have become available to comple-
ment etiological epidemiological investigations of causal associations. For example, genotypic
data were critical in linking sexual partners in the context of Ebola [44] and Shigella [23]. Stan-
dardized definitions and approaches to the investigation of sexual transmission of infectious
agents and criteria for considering a pathogen to be sexually transmissible would greatly aid
this effort. For example, is transmission by close, intimate contact (i.e., skin-to-skin) consid-
ered sexual transmission? Bradford Hill’s classic viewpoints about causation could be adapted;
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for example, molecular concordance of strains between sexual partners might be a require-
ment for demonstrating specificity of association. The establishment of an objective criteria
for determining the necessary components to consider a pathogen sexually transmitted could
complement the existing framework developed by Hill. If sexual transmission is established,
quantitative information about parameters such as incubation period, serial interval, transmis-
sion probability per coital act, and reproductive number will be needed for mathematical
modelling studies of transmission dynamics, the proportion of cases attributable to sexual
transmission, the potential for epidemic spread, and the effects of control measures. These
quantities are particularly difficult to estimate when the agent has an alternative, predominant
mode of transmission in endemic areas, e.g., mosquito-borne Zika. Developing criteria and
methodologic approaches to sexual transmission could prove invaluable if they can be applied
to key pathogens with epidemic potential, including those that the World Health Organization
has published in its blueprint of action to prevent epidemics [61]. A proactive initiative to
understand the potential for sexual transmission of such pathogens will help us to stay ahead
of the curve.
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